Fractyl Health, Inc.
GUTS
$0.9904
-$0.0196-1.94%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -85.71% | -59.46% | -22.50% | -17.80% | 45.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -85.71% | -59.46% | -22.50% | -17.80% | 45.12% |
| Cost of Revenue | -90.00% | -66.67% | -35.06% | -33.33% | 32.08% |
| Gross Profit | -79.59% | -47.27% | 0.00% | 12.50% | 68.97% |
| SG&A Expenses | -3.45% | 23.71% | 79.92% | 64.24% | 83.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.66% | 60.23% | 83.73% | 62.54% | 49.82% |
| Operating Income | -39.87% | -60.52% | -83.99% | -62.73% | -49.83% |
| Income Before Tax | -79.83% | -30.12% | 10.89% | 9.94% | 14.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -79.83% | -30.12% | 10.89% | 9.94% | 14.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -79.83% | -30.12% | 10.89% | 9.94% | 14.86% |
| EBIT | -39.87% | -60.52% | -83.99% | -62.73% | -49.83% |
| EBITDA | -39.20% | -59.69% | -83.80% | -62.91% | -50.18% |
| EPS Basic | 90.37% | 95.09% | 96.62% | 70.93% | 46.55% |
| Normalized Basic EPS | 88.14% | 91.90% | 94.03% | 59.54% | 27.66% |
| EPS Diluted | 90.37% | 95.09% | 96.62% | 70.93% | 46.55% |
| Normalized Diluted EPS | 88.14% | 91.90% | 94.03% | 59.54% | 27.66% |
| Average Basic Shares Outstanding | 137.48% | 436.53% | 1,990.82% | 1,442.83% | 894.16% |
| Average Diluted Shares Outstanding | 137.48% | 436.53% | 1,990.82% | 1,442.83% | 894.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |